Citations

Mayo Clinic

Showing 10 of 108523 citations.

Clinical Reasoning: A case of unilateral facial pain
Siegel, Jason , Harriott, Andrea M.

Neurology | May 25, 2015 | Volume: 84 | Issue: 21 | Pages: No page available

10.1212/wnl.0000000000001604 | PMID 26009565 Get It

Incidence, Severity, and Outcomes of Acute Kidney Injury in Octogenarians following Heart Valve Replacement Surgery
Tejwani, Vickram, Vela-Ortiz, Myriam, Qian, Qi , Mao, Michael A. , Dearani, Joseph, Thongprayoon, Charat , Wu, YiFan, Tejwani, Vickram, Dearani, Joseph A.

International Journal of Nephrology | May 25, 2015 | Volume: 2015 | Issue: No issue available | Pages: 1-8

10.1155/2015/237951 | PMID 26090225 Get It

Background. The study investigates the occurrence, severity, and outcomes of acute kidney injury (AKI) in octogenarians following heart valve surgery.Methods. All patients, age>80 years, not on dialysis and without kidney transplant, undergoing heart valve replacement at Mayo Clinic, Rochester, in the years 2002-2003 were enrolled. AKI was diagnosed based on AKIN criteria.Results. 209 octogenarians (88.0% aortic valve, 6.2% mitral valve, 1.0% tricuspid valve, and 4.8% multivalve) with (58.4%) and without CABG were studied. 34 (16.3%) had preexisting CKD. After surgery, 98 (46.8%) developed AKI. 76.5% of the AKI were in Stage 1, 9.2% in Stage 2, and 14.3% in Stage 3. 76.5% CKD patients developed AKI. Length of hospital stay was longer for AKI patients. More AKI patients were discharged to care facilities. Patient survival at 30 days and 1 year for AKI versus non-AKI was 88.8 versus 98.7%,p=0.003, and 76.5 versus 88.3%,p=0.025, respectively. With follow-up of3.94±0.28years, Kaplan-Meier analysis showed a reduced survival for AKI octogenarians. Preexisting CKD and large volume intraoperative fluid administration were independent AKI predictors.Conclusions. Nearly half of the octogenarians developed AKI after valve replacement surgery. AKI was associated with significant functional impairment and reduced survival.
Temozolomide induced bone marrow Suppression–A single institution outcome analysis and review of the literature
Kourelis, Taxiarchis , Buckner, Jan C. , Gangat, Naseema , Patnaik, Mrinal M. , Kourelis, Taxiarchis V

American Journal of Hematology | May 25, 2015 | Volume: 90 | Issue: 9 | Pages: No page available

10.1002/ajh.24066 | PMID 26010271 Get It

Differential activation of airway eosinophils inducesIL‐13‐mediated allergic Th2 pulmonary responses in mice
Jacobsen, Elizabeth A. , Doyle, Alfred D. , Colbert, Dana, Zellner, Katie R. , Protheroe, Cheryl, LeSuer, William E., Lee, N. A., Lee, J. J., Lee, N.A., Jacobsen, Elizabeth A

Allergy | May 23, 2015 | Volume: 70 | Issue: 9 | Pages: 1148-1159

10.1111/all.12655 | PMID 26009788 Get It

AbstractBackgroundEosinophils are hallmark cells of allergic Th2 respiratory inflammation. However, the relative importance of eosinophil activation and the induction of effector functions such as the expression ofIL‐13 to allergic Th2 pulmonary disease remain to be defined.MethodsWild‐type or cytokine‐deficient (IL‐13−/−orIL‐4−/−) eosinophils treated with cytokines (GM‐CSF,IL‐4,IL‐33) were adoptively transferred into eosinophil‐deficient recipient mice subjected to allergen provocation using established models of respiratory inflammation. Allergen‐induced pulmonary changes were assessed.ResultsIn contrast to the transfer of untreated blood eosinophils to the lungs of recipient eosinophil deficient mice, which induced no immune/inflammatory changes either in the lung or in the lung draining lymph nodes (LDLN), pretreatment of blood eosinophils withGM‐CSFprior to transfer elicited trafficking of these eosinophils toLDLN. In turn, theseLDLNeosinophils elicited the accumulation of dendritic cells andCD4+T cells to these sameLDLNs without inducing pulmonary inflammation. However, exposure of eosinophils toGM‐CSF,IL‐4, andIL‐33 prior to transfer induced not only immune events in theLDLN, but also allergen‐mediated increases in airway Th2 cytokine/chemokine levels, the subsequent accumulation ofCD4+T cells as well as alternatively activated (M2) macrophages, and the induction of pulmonary histopathologies. Significantly, this allergic respiratory inflammation was dependent on eosinophil‐derivedIL‐13, whereasIL‐4 expression by eosinophils had no significant role.ConclusionThe data demonstrate the differential activation of eosinophils as a function of cytokine exposure and suggest that eosinophil‐specificIL‐13 expression by activated cells is a necessary component of the subsequent allergic Th2 pulmonary pathologies.
Postprandial Hemodynamics in Hypertrophic Cardiomyopathy
Adams, Jonathon C., Bois, John P. , Masaki, Mitsuru, Yuasa, Toshinori , Oh, Jae K. , Ommen, Steve R. , Klarich, Kyle W. , Nishimura, Rick A.

Echocardiography | May 23, 2015 | Volume: 32 | Issue: 11 | Pages: 1614-1620

10.1111/echo.12951 | PMID 26010128 Get It

ObjectivesPrior analysis at our institution found that patients with hypertrophic cardiomyopathy (HCM) who experience postprandial symptoms (PPS) are more likely to have resting left ventricular outflow tract (LVOT) obstruction and reduced quality of life. Our objective was to determine whether PPS in patients with HCM vs healthy subjects occur as a result of measurable hemodynamic alterations in the postprandial hemodynamic response.MethodsWe conducted a prospective cross‐sectional study examining 45 patients with HCM and 10 controls who underwent fasting and postprandial 2‐dimensional Doppler echocardiography. Postprandial echocardiographic measurements were obtained at symptom onset or 30 minutes after consumption of a standardized meal, whichever occurred first.ResultsThe HCM population included 18 (40%) patients with PPS and 27 (60%) without PPS. Compared to controls, mean resting peak LVOT gradient was 23.4 ± 17.6 mmHg in HCM patients with PPS and 25.1 ± 33.1 mmHg in those without PPS (P = 0.10). The mean change in peak LVOT gradient after a meal was 0.7 ± 1.1 mmHg for controls, 5.0 ± 8.3 mmHg for HCM patients with PPS, and 1.5 ± 18.2 mmHg for HCM patients without PPS (P = 0.64).ConclusionAlthough the ability to provoke an increased LVOT gradient with a postprandial, upright exercise study protocol was recently reported, the current study suggests that a resting, supine, postprandial protocol does not elicit evidence of LVOT obstruction. Therefore, future investigations should consider whether simply performing an upright postprandial study in HCM patients with PPS will provide evidence of dynamic LVOT or if the addition of an exercise component is necessary.
Clinical Use of Pulse Wave Analysis: Proceedings From a Symposium Sponsored by North American Artery
Black, Henry R., Chirinos, Julio A. , Feig, Peter U., Ferdinand, Keith C. , Germain, Michael, Rosendorff, Clive , Steigerwalt, Susan, Stepanek, Jan A, Townsend, Raymond R. , Stepánek, Jan

The Journal of Clinical Hypertension | May 23, 2015 | Volume: 17 | Issue: 7 | Pages: 503-513

10.1111/jch.12574 | PMID 26010834 Get It

The use of pulse wave analysis may guide the provider in making choices about blood pressure treatment in prehypertensive or hypertensive patients. However, there is little clinical guidance on how to interpret and use pulse wave analysis data in the management of these patients. A panel of clinical researchers and clinicians who study and clinically use pulse wave analysis was assembled to discuss strategies for using pulse wave analysis in the clinical encounter. This manuscript presents an approach to the clinical application of pulse waveform analysis, how to interpret central pressure waveforms, and how to use existing knowledge about the pharmacodynamic effect of antihypertensive drug classes in combination with brachial and central pressure profiles in clinical practice. The discussion was supplemented by case‐based examples provided by panel members, which the authors hope will provoke discussion on how to understand and incorporate pulse wave analysis into clinical practice.
Embolization of Veno-venous Collaterals after the Fontan Operation Is Associated with Decreased Survival
Poterucha, Joseph T., Johnson, Jonathan N. , Taggart, Nathaniel W. , Hagler, Donald J. , Driscoll, David J. , Cetta, Frank , Taggart, Nathan W, Cabalka, Allison K. , Taggart, Nathaniel W

Congenital Heart Disease | May 23, 2015 | Volume: 10 | Issue: 5 | Pages: E230-E236

10.1111/chd.12276 | PMID 26010433 Get It

Journal status: Update from your Editor‐in‐Chief Rokea A. el‐Azhary, MD, PhD
el‐Azhary, Rokea A.

International Journal of Dermatology | May 23, 2015 | Volume: 54 | Issue: 6 | Pages: 615-615

10.1111/ijd.13070 Get It

Emerging therapies for the prevention of acute respiratory distress syndrome
Ruthman, Carl, Festić, Emir , Ruthman, Carl A

Therapeutic Advances in Respiratory Disease | May 23, 2015 | Volume: 9 | Issue: 4 | Pages: 173-187

10.1177/1753465815585716 | PMID 26002528 Get It

The development of acute respiratory distress syndrome (ARDS) carries significant risk of morbidity and mortality. To date, pharmacological therapy has been largely ineffective for patients with ARDS. We present our personal review aimed at outlining current and future directions for the pharmacological prevention of ARDS. Several available risk-stratification or prediction score strategies for identification of patients at risk of ARDS have been reported. Although not ready for clinical everyday use, they are and will be instrumental in the ongoing and future trials of pharmacoprevention of ARDS. Several systemic medications established the potential role in ARDS prevention based on the preclinical studies and observational data. Due to potential for systemic adverse effects to neutralize any pharmacological benefits of systemic therapy, inhaled medications appear particularly attractive candidates for ARDS prevention. This is because of their direct delivery to the site of proposed action (lungs), while the pulmonary epithelial surface is still functional. We postulate that overall morbidity and mortality rates from ARDS in the future will be contingent upon decreasing the overall incidence of ARDS through effective identification of those at risk and early application of proven supportive care and pharmacological interventions.
Improving the detection of chronic migraine: Development and validation of Identify Chronic Migraine (ID-CM)
Serrano, Daniel , Buse, Dawn C. , Pavlović, Jelena , Blumenfeld, Andrew , Aurora, Sheena K. , Becker, Werner J. , Wang, Shuu‐Jiun , Vincent, Maurice , Hindiyeh, Nada , Starling, Amaal J. , Gillard, Patrick, Varon, Sepideh F., Reed, Michael L. , Lipton, Richard B. , Pavlovic, Jelena M. , Dodick, David W. , Diener, Hans‐Christoph , Wang, Shuu-Jiun

Cephalalgia | May 22, 2015 | Volume: 36 | Issue: 3 | Pages: 203-215

10.1177/0333102415583982 | PMID 26002700 Get It

Background Migraine, particularly chronic migraine (CM), is underdiagnosed and undertreated worldwide. Our objective was to develop and validate a self-administered tool (ID-CM) to identify migraine and CM. Methods ID-CM was developed in four stages. (1) Expert clinicians suggested candidate items from existing instruments and experience (Delphi Panel method). (2) Candidate items were reviewed by people with CM during cognitive debriefing interviews. (3) Items were administered to a Web panel of people with severe headache to assess psychometric properties and refine ID-CM. (4) Classification accuracy was assessed using an ICHD-3β gold-standard clinician diagnosis. Results Stages 1 and 2 identified 20 items selected for psychometric validation in stage 3 ( n = 1562). The 12 psychometrically robust items from stage 3 underwent validity testing in stage 4. A scoring algorithm applied to four symptom items (moderate/severe pain intensity, photophobia, phonophobia, nausea) accurately classified most migraine cases among 111 people (sensitivity = 83.5%, specificity = 88.5%). Augmenting this algorithm with eight items assessing headache frequency, disability, medication use, and planning disruption correctly classified most CM cases (sensitivity = 80.6%, specificity = 88.6%). Discussion ID-CM is a simple yet accurate tool that correctly classifies most individuals with migraine and CM. Further testing in other settings will also be valuable.